Q1 2022 Cytosorbents Corp Earnings Call Transcript
Good afternoon, and welcome to the Cytosorbents Corp.'s First Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that the call will be recorded at the company's request.
At this time, I would like to turn the call over to our moderator, Terri Anne Powers, Vice President of Investor Relations and Corporate Communications. Please go ahead Ms. Powers.
Thank you, Stacy. Good afternoon.
Welcome to the Cytosorbents' First Quarter 2022 Financial and Operating Results Conference Call. Joining me today from the company are Dr. Phillip Chan, our Chief Executive Officer; Vincent Capponi, President and Chief Operating Officer; Kathleen Bloch, Chief Financial Officer; Dr. Efthymios Deliargyris, our Chief Medical Officer; Dr. Christian Steiner, Executive Vice President of Sales and Marketing and Managing Director of Cytosorbents Europe; and Christopher Cramer, our Vice President of Business Development.
Before I turn the call over
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |